May 14
|
4 Stocks With Impressive Interest Coverage Ratio to Buy Now
|
May 14
|
Halozyme, J&J slide as analyst cuts rating on CMS draft guidance
|
May 14
|
Why Halozyme Therapeutics, Inc. (HALO) Declined on Tuesday
|
May 13
|
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
|
May 12
|
Is Halozyme Therapeutics (HALO) the Unstoppable Growth Stock to Invest in Now?
|
May 12
|
3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
|
May 10
|
S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points
|
May 9
|
Halozyme Therapeutics (HALO) is a Great Momentum Stock: Should You Buy?
|
May 9
|
Halozyme Therapeutics, Inc. (HALO): Among the Best Cancer Stocks to Invest in for Long-Term Gain
|
May 8
|
Halozyme Therapeutics First Quarter 2025 Earnings: Beats Expectations
|
May 8
|
Why Halozyme Therapeutics, Inc. (HALO) Skyrocketed On Wednesday
|
May 7
|
HALO Stock Up on Q1 Earnings and Revenue Beat, Raised 2025 View
|
May 7
|
Halozyme Therapeutics Inc (HALO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
|
May 6
|
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
|
May 6
|
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS
|
May 5
|
Halozyme to Participate in the BofA Securities 2025 Healthcare Conference
|
Apr 24
|
Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation
|
Mar 13
|
Halozyme Stock Offers Early Buy Point As Company Hits $1 Billion In Revenue
|
Mar 13
|
Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
|
Mar 11
|
HALO vs. AMGN: Which Stock Is the Better Value Option?
|